A team dedicated to the future of ophthalmic innovation
At Outlook Therapeutics, we’re bringing LYTENAVA™ (bevacizumab-vikg) injection, the first and only FDA-approved ophthalmic bevacizumab formulation for the treatment of neovascular (wet) age-related macular degeneration (nAMD), to retina specialists and their patients. Join a team committed to advancing ophthalmic therapies and improving the lives of patients with retinal diseases.
You can also join our talent community by sending your resume or curriculum vitae (CV) to HR@outlooktherapeutics.com. We’ll keep your information on file and contact you when a position aligns with your experience and interests.
By submitting your information, you acknowledge that you have read and agree to our Privacy notice
Why work with us?
At Outlook Therapeutics, our people are our greatest strength. We’re building a collaborative, innovative culture where every team member has the opportunity to make a meaningful impact on patients, physicians, and the future of ophthalmic care.
Employee benefits
– Competitive compensation
– Comprehensive medical, dental, and vision coverage
– 401(k) with company match
– Paid time off and company holidays
– Flexible work arrangements
– Professional development opportunities
– Employee wellness resources
A culture of collaboration
From your first day, you’ll work alongside experienced professionals who are passionate about advancing ophthalmic innovation. We foster an environment that values collaboration, continuous learning, and shared success as we bring new therapies to the retina community.
